Tyra Biosciences, Inc.
TYRA
$12.20
$0.504.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.73% | -8.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.25% | 7.08% | |||
| Operating Income | 1.25% | -7.08% | |||
| Income Before Tax | 0.17% | -10.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.17% | -10.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.17% | -10.07% | |||
| EBIT | 1.25% | -7.08% | |||
| EBITDA | 1.25% | -7.12% | |||
| EPS Basic | 0.55% | -9.56% | |||
| Normalized Basic EPS | 0.54% | -9.57% | |||
| EPS Diluted | 0.55% | -9.56% | |||
| Normalized Diluted EPS | 0.54% | -9.57% | |||
| Average Basic Shares Outstanding | 0.36% | 0.47% | |||
| Average Diluted Shares Outstanding | 0.36% | 0.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||